Cell Culture and Tissue Morphology Core
细胞培养和组织形态学核心
基本信息
- 批准号:8744879
- 负责人:
- 金额:$ 15.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-01 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimal ModelAnimalsArchivesBreedingCDK4 geneCancer cell lineCell Culture TechniquesCell LineCellsChargeChildClinicalClinical ResearchCollectionComplementary DNACyclin-Dependent Kinase Inhibitor 2ADatabasesDevelopmentElectronic MailEmbryoEpithelialEpithelial CellsFamilyFibroblastsFreezingGastrointestinal NeoplasmsGastrointestinal tract structureGene DeletionGene MutationGenerationsGenesHepaticHistopathologyHospitalsHousingHumanHuman Cell LineImmunohistochemistryIndividualKnockout MiceLaboratoriesLiverMaintenanceMalignant NeoplasmsMalignant neoplasm of gastrointestinal tractMalignant neoplasm of pancreasMissionMolecularMorphologyMouse Cell LineMucous MembraneMusMutateNormal tissue morphologyOperative Surgical ProceduresPancreasPancreatic carcinomaParaffin EmbeddingPartner in relationshipPatternPharmaceutical PreparationsPhenotypePlayPrimary carcinoma of the liver cellsProteinsReagentResearch PersonnelRoleSecureServicesSignal TransductionSimian virus 40SingaporeSourceSpecimenStomachStomach CarcinomaTelomeraseTemperatureTissue MicroarrayTissuesTransgenic MiceTranslatingTranslational ResearchTreatment EfficacyTumor BankTumor Cell LineTumor TissueUniversitiesUniversity HospitalsVirusWorkanticancer researchc-Myc Staining Methodcarcinogenesisexpression vectorfollow-upgastrointestinalinterestintestinal epitheliummeetingsmembermouse modelneoplastic cellnovel therapeuticsprogramsrecombinant virusresearch studytemperature sensitive mutanttissue/cell culturetumor
项目摘要
The Cell Culture Subcore will generate and maintain primary cultures and cell lines from various tissues and origins including human cancers, tumors in knockout mice, and mouse embryonic fibroblasts derived from genetically modified mice. Our mission is to generate and characterize human and mouse gastrointestinal tumor/cancer cell lines, which will be utilized for exploring the cellular and molecular mechanisms in gastrointestinal carcinogenesis. One of the major impediments in gastrointestinal cancer research has been the lack of normal epithelial cell lines derived from gastrointestinal tissues. To address this deficiency, the subcore will provide a service in developing epithelial cell lines from the different segments of the gastrointestinal tract of transgenic mice with gene deletions known to be associated with gastrointestinal tumor/cancer development. We will also generate epithelial cell lines from the different segments of human gastrointestinal tissues including pancreas, stomach and liver. Finally, the subcore is responsible for generation and maintenance of large-scale stocks of recombinant virus. The Tissue Morphology Subcore provides to the Program a comprehensive histopathology and tumor acquisition service. The mission of the core is to: 1) acquire human and gastrointestinal tumor/normal tissues (hepatocellular, pancreatic, and gastric)-fresh, snap frozen and paraffin embedded-from surgical procedures performed at Georgetown University Hospital (GUH) or from animal models generated by the animal models core (core A), respectively, and distribute these tumor and normal tissues to all four projects of the program as well as to the Cell Culture Subcore to generate cell lines; 2) maintain the tumor bank that will include the Georgetown University (GU) extensive in house collections of Gl tumors, as well as additional tissues obtained by the individual project leaders to enhance the existing GU collections (e.g. The Singapore collection of frozen and normal HCC specimens with compete clinical follow up (SingHealth HCC specimens) obtained by Dr. Byers-Project 2 and the Toronto Hospital for Sick Children's extensive collection of BWS tumors obtained by Dr. L. Mishra-Project 1); 3) provide a comprehensive tissue histological services, including state of the art tissue microarray and immunohistochemistry; and 4) provide expert assistance in conducting and interpreting experiments using specimens from human and animal subjects. Both subcores will function as a synergistic hub in the Program by working closely with each project leader as well as with the other cores (Animal Models Core-Core A and Administrative Core-Core C) to insure that the proper tissues are obtained/archived/frozen and the necessary human and mouse cell lines are generated.
细胞培养亚核心将产生和维持来自各种组织和来源的原代培养和细胞系,包括人类癌症、基因敲除小鼠肿瘤和来自转基因小鼠的小鼠胚胎成纤维细胞。我们的任务是生成和表征人类和小鼠胃肠道肿瘤/癌细胞系,这将用于探索胃肠道癌变的细胞和分子机制。胃肠道肿瘤研究的主要障碍之一是缺乏来自胃肠道组织的正常上皮细胞系。为了解决这一缺陷,该亚核心将提供一种服务,用于开发来自胃肠道不同部分的上皮细胞系,这些基因缺失已知与胃肠道肿瘤/癌症的发展相关。我们还将从人体胃肠道组织的不同部分,包括胰腺、胃和肝脏中产生上皮细胞系。最后,亚核负责产生和维持重组病毒的大规模储存。组织形态学亚核心为该计划提供全面的组织病理学和肿瘤采集服务。核心的任务是:1)分别从乔治城大学医院(GUH)进行的外科手术中或从动物模型核心(核心A)生成的动物模型中获取新鲜、速冻和石蜡包埋的人类和胃肠道肿瘤/正常组织(肝细胞、胰腺和胃),并将这些肿瘤和正常组织分配给该计划的所有四个项目以及细胞培养亚核心以产生细胞系;2)维护肿瘤库,包括乔治城大学(GU)大量的Gl肿瘤收藏;以及由个别项目负责人获得的额外组织,以加强现有的GU收集(例如,byers博士项目2获得的新加坡冷冻和正常HCC标本(SingHealth HCC标本),以及L. mishra博士项目1获得的多伦多病儿医院广泛收集的BWS肿瘤);3)提供全面的组织组织学服务,包括最先进的组织微阵列和免疫组织化学;4)在使用人类和动物受试者的标本进行和解释实验方面提供专家协助。这两个子核心都将作为项目的协同中心,与每个项目负责人以及其他核心(动物模型核心-核心a和管理核心-核心C)密切合作,以确保获得/存档/冷冻适当的组织,并生成必要的人类和小鼠细胞系。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHULIN LI其他文献
SHULIN LI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHULIN LI', 18)}}的其他基金
Tumor-Targeted Chemo-Immunotherapy for Osteosarcoma Metastasis
骨肉瘤转移的肿瘤靶向化学免疫治疗
- 批准号:
9294022 - 财政年份:2016
- 资助金额:
$ 15.22万 - 项目类别:
Tumor-Targeted Chemo-Immunotherapy for Osteosarcoma Metastasis
骨肉瘤转移的肿瘤靶向化学免疫治疗
- 批准号:
9175963 - 财政年份:2016
- 资助金额:
$ 15.22万 - 项目类别:
Tumor-Targeted Chemo-Immunotherapy for Osteosarcoma Metastasis
骨肉瘤转移的肿瘤靶向化学免疫治疗
- 批准号:
9926814 - 财政年份:2016
- 资助金额:
$ 15.22万 - 项目类别:
Low Electric Field-Based Gene Delivery of IL-30 Gene Therapy for Liver Injury
基于低电场的 IL-30 基因递送基因治疗肝损伤
- 批准号:
9254540 - 财政年份:2015
- 资助金额:
$ 15.22万 - 项目类别:
Low Electric Field-Based Gene Delivery of IL-30 Gene Therapy for Liver Injury
基于低电场的 IL-30 基因递送基因治疗肝损伤
- 批准号:
9050669 - 财政年份:2015
- 资助金额:
$ 15.22万 - 项目类别:
Low Electric Field-Based Gene Delivery of IL-30 Gene Therapy for Liver Injury
基于低电场的 IL-30 基因递送基因治疗肝损伤
- 批准号:
8882981 - 财政年份:2015
- 资助金额:
$ 15.22万 - 项目类别:
IL12 Gene Therapy For Enhancing Therapeutic Efficacy of Bleomycin Against Oral Tu
IL12基因疗法增强博来霉素抗口腔肿瘤的疗效
- 批准号:
8512669 - 财政年份:2010
- 资助金额:
$ 15.22万 - 项目类别:
IL12 Gene Therapy For Enhancing Therapeutic Efficacy of Bleomycin Against Oral Tu
IL12基因疗法增强博莱霉素抗口腔肿瘤的疗效
- 批准号:
8142751 - 财政年份:2010
- 资助金额:
$ 15.22万 - 项目类别:
IL12 Gene Therapy For Enhancing Therapeutic Efficacy of Bleomycin Against Oral Tu
IL12基因疗法增强博来霉素抗口腔肿瘤的疗效
- 批准号:
8699156 - 财政年份:2010
- 资助金额:
$ 15.22万 - 项目类别:
IL12 Gene Therapy For Enhancing Therapeutic Efficacy of Bleomycin Against Oral Tu
IL12基因疗法增强博莱霉素抗口腔肿瘤的疗效
- 批准号:
7767449 - 财政年份:2010
- 资助金额:
$ 15.22万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 15.22万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 15.22万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 15.22万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 15.22万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 15.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 15.22万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 15.22万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 15.22万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 15.22万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 15.22万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




